Regulators in the United Kingdom issued guidance on Thursday, warning that weight loss and diabetes medications may weaken ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Continue reading to learn what compounded tirzepatide is and how it compares with Mounjaro. Drug compounding is a process in which a licensed pharmacist creates a custom alternative to an FDA ...